Virtu Financial’s POMDOCTOR LIMITED Class A Ordinary Shares POM Stock Holding History

Virtu Financial’s Portfolio POM Stock Details POM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-975	Closed	-$5K	–	2459
2026 Q1	$5K	Buy	+975	New	+$5K	﹤0.01%	1515

Other funds holding POM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Virtu Financial's POM Position: Q2 2026 in Review

Virtu Financial sold out of POMDOCTOR LIMITED Class A Ordinary Shares (POM) in Q2 2026, closing a stake of 975 shares — an estimated $5K sold.

Virtu Financial first reported a position in POM in Q1 2026 and held it in 1 quarter. The position peaked at $5K in Q1 2026. 6 funds tracked by Wall St. Rank hold POM as of Q2 2026.

Virtu Financial reported no remaining POMDOCTOR LIMITED Class A Ordinary Shares position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 975 POMDOCTOR LIMITED Class A Ordinary Shares shares in Q2 2026, an estimated $5K.
Virtu Financial first reported a position in POMDOCTOR LIMITED Class A Ordinary Shares in Q1 2026 and held it in 1 quarter.
Virtu Financial's POMDOCTOR LIMITED Class A Ordinary Shares position peaked at $5K in Q1 2026.
6 funds tracked by Wall St. Rank held POMDOCTOR LIMITED Class A Ordinary Shares as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.